Colon Polyps Clinical Trials

• Evaluation of Stool Tagging for Improved Patient Compliance
  ClinicalTrials.gov Identifier: NCT00124163 - Recruiting
  Colon Cancer; Polyps
  
• Calcium, Vitamin D, and Colon Cancer Risk Biomarkers
  ClinicalTrials.gov Identifier: NCT00208793 - Active, not recruiting
  Colonic Polyps; Adenomatous Polyps
  
• Calcium/Vitamin D, Biomarkers,& Colon Polyp Prevention
  ClinicalTrials.gov Identifier: NCT00399607 - Recruiting
  Adenomatous Colon Polyps
  
• Reduction of Conscious Sedation Requirements by Olfactory Stimulation
  ClinicalTrials.gov Identifier: NCT00417001 - Recruiting
  Colon Cancer; Health Screening; Colon Polyps
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients with Colon Polyps
  ClinicalTrials.gov Identifier: NCT00118365 - Active, not recruiting
  Colon Cancer; Rectal Cancer; Precancerous Condition
  
• Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients Who Have Had Surgery to Remove Benign Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00005882 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa
  ClinicalTrials.gov Identifier: NCT00432913 - Recruiting
  Adenomatous Polyps
  
• Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
  ClinicalTrials.gov Identifier: NCT00026468 - Active, not recruiting
  Colon Cancer; Rectal Cancer; small intestine cancer
  
• High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002650 - Active, not recruiting
  Rectal Cancer; prevention of colorectal cancer; Colon Cancer
  
• Celecoxib and/or Selenium in Treating Patients With Adenomatous Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00078897 - Recruiting
  Colon Cancer; Rectal Cancer
  
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
  ClinicalTrials.gov Identifier: NCT00005094 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-Finding Study
  ClinicalTrials.gov Identifier: NCT00285701 - Recruiting
  Colorectal Cancer
  
• Effect of Vitamin D and Calcium on Genes in the Colon
  ClinicalTrials.gov Identifier: NCT00298545 - Recruiting
  Pre-Cancerous Colorectal Polyps; Familial Colorectal Adenoma; Adenocarcinoma
  
• Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
  ClinicalTrials.gov Identifier: NCT00141193 - Active, not recruiting
  Colorectal Sporadic Adenomatous Polyps
  
• Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00512850 - Active, not recruiting
  Colorectal Cancer
  
• Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
  ClinicalTrials.gov Identifier: NCT00087256 - Completed
  stage I colon cancer; adenocarcinoma of the colon
  
• Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
  ClinicalTrials.gov Identifier: NCT00550628 - Recruiting
  Colorectal Cancer; Neoplasm of Uncertain Malignant Potential
  
• Chemoprevention with Folic Acid
  ClinicalTrials.gov Identifier: NCT00018551 - Completed
  Colon Cancer; Adenoma; Colonic Polyps
  
• Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003485 - Active, not recruiting
  stage IV colon cancer; recurrent colon cancer; adenocarcinoma of the colon
  
• Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00033319 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Curcumin for the Chemoprevention of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00118989 - Recruiting
  Adenomatous Polyps
  
• Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00002575 - Active, not recruiting
  stage III colon cancer; stage I colon cancer; adenocarcinoma of the colon; stage II colon cancer
  
• Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00062023 - Active, not recruiting
  Colorectal Cancer; stage I colon cancer; stage II colon cancer; stage III colon cancer; stage IV colon cancer
  
• Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00131599 - Active, not recruiting
  -colon cancer
  
• Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between the Ages of 6 and Less Than 18 Years Old (Study P04292)
  ClinicalTrials.gov Identifier: NCT00378378 - Recruiting
  Nasal Polyps
  
• Genetic Study of Familial Factors in Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00055848 - Recruiting
  adenocarcinoma of the colon; stage I colon cancer; stage II colon cancer; stage III colon cancer; stage IV colon cancer
  
• Mint Tea for the Treatment of Nasal Polyps
  ClinicalTrials.gov Identifier: NCT00465543 - Recruiting
  Nasal Polyps
  
• Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
  ClinicalTrials.gov Identifier: NCT00091312 - Active, not recruiting
  stage II colon cancer; adenocarcinoma of the colon
  
• Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002525 - Active, not recruiting
  stage II colon cancer; stage III colon cancer
  
• Gene Therapy in Patients With Colon Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00012155 - Active, not recruiting
  recurrent colon cancer; liver metastases; stage IV colon cancer; adenocarcinoma of the colon
  
• Combination Chemotherapy in Treating Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00046995 - Recruiting
  adenocarcinoma of the colon; stage II colon cancer; stage III colon cancer
  
• High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00004150 - Active, not recruiting
  stage III colon cancer; adenocarcinoma of the colon; mucinous adenocarcinoma of the colon
  
• Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00096278 - Active, not recruiting
  adenocarcinoma of the colon; stage II colon cancer; stage III colon cancer
  
• Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00005979 - Active, not recruiting
  stage III colon cancer; adenocarcinoma of the colon
  
• Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00008060 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006468 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Antineoplaston Therapy in Treating Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003486 - Recruiting
  stage IV colon cancer; recurrent colon cancer; adenocarcinoma of the colon
  
• Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
  ClinicalTrials.gov Identifier: NCT00085163 - Active, not recruiting
  adenocarcinoma of the colon; stage III colon cancer
  
• Monoclonal Antibody Therapy Compared With No Further Therapy After Surgery in Treating Patients With Stage II Colon Cancer
  ClinicalTrials.gov Identifier: NCT00002968 - Active, not recruiting
  stage II colon cancer; adenocarcinoma of the colon
  
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00025142 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• SU011248 in Treating Patients With Metastatic Colorectal Adenocarcinoma (Cancer) That Has Not Responded to Previous Treatment With Irinotecan, Oxaliplatin, and a Fluoropyrimidine With or Without Bevacizumab
  ClinicalTrials.gov Identifier: NCT00082771 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; ...
  
• FishGastro Study
  ClinicalTrials.gov Identifier: NCT00145015 - Recruiting
  Colorectal Cancer; Ulcerative Colitis; Polyps
  
• Immediate Compared With Delayed Chemotherapy in Treating Patients With Advanced Colorectal Cancer Without Signs or Symptoms of Disease
  ClinicalTrials.gov Identifier: NCT00002570 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00112918 - Active, not recruiting
  stage II colon cancer; stage III colon cancer
  
• Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
  ClinicalTrials.gov Identifier: NCT00077233 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016952 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
  ClinicalTrials.gov Identifier: NCT00025337 - Active, not recruiting
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; ...
  
• Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00075595 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• CHOICE: Communicating Health Options Through Information and Cancer Education
  ClinicalTrials.gov Identifier: NCT00134589 - Recruiting
  Colorectal Neoplasms; Rectal Neoplasms; Colonic Polyps
  
• An Effectiveness & Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00261599 - Completed
  Colonoscopy; Colon Polyps; Endoscopic Outcomes; Endoscopic Sedation; Endoscopy; Conscious Sedation
  
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006115 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy, Bevacizumab, and Cetuximab in Treating Patients With Stage IV Colorectal Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00100841 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003260 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004102 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00039208 - Active, not recruiting
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00126867 - Recruiting
  Colon Cancer
  
• Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00062426 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
  
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003287 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; adenocarcinoma of the rectum; recurrent rectal cancer; stage IV colon cancer; ...
  
• Comparison of Three Chemotherapy Regimens in Treating Patients with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00008281 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00098982 - Active, not recruiting
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00031616 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer
  ClinicalTrials.gov Identifier: NCT00393822 - Active, not recruiting
  Colon Cancer
  
• Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004252 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; adenocarcinoma of the colon
  
• Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00040820 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
  
• Lymph Node Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I, Stage II, or Stage III Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005640 - Active, not recruiting
  stage I rectal cancer; stage I colon cancer; stage III colon cancer; stage III rectal cancer; stage II colon cancer; stage II rectal cancer
  
• Chemotherapy Administered Every 2 Weeks with or without Pegfilgrastim (Neulasta) in Subjects with Advanced Colon Cancer
  ClinicalTrials.gov Identifier: NCT00094809 - Active, not recruiting
  Colon Cancer; Colorectal Cancer; Rectal Cancer
  
• Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00134069 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002893 - Active, not recruiting
  recurrent colon cancer; stage III rectal cancer; Stage IV rectal cancer; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00021281 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; ...
  
• Vitamin D/Calcium Polyp Prevention Study
  ClinicalTrials.gov Identifier: NCT00153816 - Recruiting
  Colorectal Cancer; Polyps; Adenomas
  
• OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00081237 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00004931 - Active, not recruiting
  stage III colon cancer; stage II colon cancer
  
• Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
  ClinicalTrials.gov Identifier: NCT00002455 - Active, not recruiting
  Breast Cancer; Colon Cancer; Melanoma
  
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00079274 - Recruiting
  stage III colon cancer; adenocarcinoma of the colon
  
• SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00103311 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00064181 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer
  
• Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003543 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006001 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
  
• Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer
  ClinicalTrials.gov Identifier: NCT00016029 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• ABX-EGF in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Chemotherapy
  ClinicalTrials.gov Identifier: NCT00087243 - Recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
  
• Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00072553 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003950 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00004142 - Active, not recruiting
  recurrent colon cancer; liver metastases; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002793 - Active, not recruiting
  recurrent colon cancer; liver metastases; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00019747 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003441 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005877 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00104689 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00033306 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Capecitabine in Treating Older Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00049335 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Outcomes in Education and Counseling for HNPCC Testing
  ClinicalTrials.gov Identifier: NCT00001470 - Recruiting
  Colonic Neoplasm; Colonic Polyps; Hereditary Neoplastic Syndrome
  
• Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016198 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Study Evaluating Isovorin in Colon Cancer
  ClinicalTrials.gov Identifier: NCT00195585 - Active, not recruiting
  Colon Cancer
  
• Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00080951 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002527 - Active, not recruiting
  stage I rectal cancer; stage I colon cancer; prevention of colorectal cancer; stage III colon cancer; stage III rectal cancer; stage II colon cancer; ...
  
• Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00006269 - Active, not recruiting
  recurrent colon cancer; Diarrhea; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• R115777 in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005833 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004187 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003873 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...